Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2000
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075137A1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075136A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075134A1 Pyrazinone thrombin inhibitors
12/14/2000WO2000075133A1 Novel isoquinoline derivatives or salts thereof
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
12/14/2000WO2000075115A1 Pernasal preparations
12/14/2000WO2000075108A1 Inhibitors of metalloproteinases
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074710A2 Methods for treating diabetes
12/14/2000WO2000074707A2 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation
12/14/2000WO2000074684A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
12/14/2000WO2000074682A1 Thrombin inhibitors
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074651A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
12/14/2000WO2000074584A1 Devices and methods for treating tissue
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049135A3 Substrate for cell growth
12/14/2000WO2000047716A3 Fibres for culturing eukaryotic cells
12/14/2000WO2000047568A3 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
12/14/2000WO2000047284A3 Novel use of orexin receptor antagonists
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376358A1 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375843A1 Compositions and methods for inhibiting cell death
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375702A1 Nasal preparations
12/14/2000CA2375617A1 Targeted angiogenesis
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2374654A1 Thrombin inhibitors
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374460A1 Inhibitors of metalloproteinases
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2373336A1 Peroxynitrite decomposition catalysts and methods of use thereof
12/13/2000EP1059302A1 Factor VIIa inhibitors
12/13/2000EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058684A1 Glycine transport inhibitors
12/13/2000EP1058683A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/13/2000EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
12/13/2000EP1058550A1 Substituted semicarbazides and the use thereof
12/13/2000EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP0724583B1 Pyridazino quinoline compounds
12/13/2000CN1276786A 3-aryl-succinamido-hydroxamic acids, method for producing said acids and medicaments contg. same
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276724A Eprosartan arginyl charge-neutralization-complex and process for its production and formulation
12/13/2000CN1276381A Application of growth factor neuregulin and its analogs
12/13/2000CN1276236A Exterior-applied medical liquor
12/13/2000CN1276222A Extract of Aralia mandshurica bark and its application
12/13/2000CN1276220A Chinese-medicinal capsule for preventing and treating cerebral apoplexy
12/13/2000CN1276214A Medicine for treating hemiplegia sequela caused by cerebrovascular accident
12/13/2000CN1276212A Functional oligose food
12/13/2000CN1059444C Method for extracting crocin for preventing and treating angicardiopathy
12/13/2000CN1059441C Benzopyranols, their preparing method, and their pharmaceutical composition and use
12/13/2000CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv.
12/13/2000CN1059433C Arylalkyl (thio) carboxamides, processes forpreparing them and pharmaceutial composition contg. them
12/13/2000CN1059342C Chinese medicine capsule for treatment of obstruction of 'qi' in chest
12/13/2000CN1059339C Chinese medicine for treatment of migraine and method for preparing same
12/13/2000CN1059338C Chinese medicine for treating cerebral vascular diseases and its producing method
12/13/2000CN1059337C Chinese medicine for lowering PTA rear narrow relapse rate
12/13/2000CN1059324C Bones and tendon recovery cream
12/12/2000US6160114 Useful for the treatment of atherosclerotic conditions and coronary heart disease
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160008 Pharmaceutical compositions comprising S-alkylisothiouronium derivatives
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159997 Treatment of arteriosclerosis and xanthoma
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/12/2000US6159964 Vitronectin receptor antagonists
12/12/2000US6159946 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
1 ... 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 ... 1595